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promoted migration of mesenchymal stem cells
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exosomal release
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Abstract
Bone marrow-derived human mesenchymal stem cells (hMSCs) are recruited to damaged or inflamed tissues where
they contribute to tissue repair. This multi-step process involves chemokine-directed invasion of hMSCs and on-site
release of factors that influence target cells or tumor tissues. However, the underlying molecular mechanisms are
largely unclear. Previously, we described that microRNA let-7f controls hMSC differentiation. Here, we investigated the
role of let-7f in chemotactic invasion and paracrine anti-tumor effects. Incubation with stromal cell-derived factor-1α
(SDF-1α) or inflammatory cytokines upregulated let-7f expression in hMSCs. Transfection of hMSCs with let-7f mimics
enhanced CXCR4-dependent invasion by augmentation of pericellular proteolysis and release of matrix
metalloproteinase-9. Hypoxia-induced stabilization of the hypoxia-inducible factor 1 alpha in hMSCs promoted cell
invasion via let-7f and activation of autophagy. Dependent on its endogenous level, let-7f facilitated hMSC motility
and invasion through regulation of the autophagic flux in these cells. In addition, secreted let-7f encapsulated in
exosomes was increased upon upregulation of endogenous let-7f by treatment of the cells with SDF-1α, hypoxia, or
induction of autophagy. In recipient 4T1 tumor cells, hMSC-derived exosomal let-7f attenuated proliferation and
invasion. Moreover, implantation of 3D spheroids composed of hMSCs and 4T1 cells into a breast cancer mouse model
demonstrated that hMSCs overexpressing let-7f inhibited tumor growth in vivo. Our findings provide evidence that
let-7f is pivotal in the regulation of hMSC invasion in response to inflammation and hypoxia, suggesting that exosomal
let-7f exhibits paracrine anti-tumor effects.
Introduction
Human mesenchymal stem cells (hMSCs) are in the
focus of intensive efforts worldwide, directed not only at
elucidating their nature and unique properties, but also
directed at developing cell- and secretome-based thera-
pies for a diverse range of diseases. hMSCs were first
isolated from bone marrow1. Presently, it is known that
hMSCs exist in all tissues. In response to chemotactic
signals such as SDF-1α and its receptor CXCR4, hMSCs
are able to invade through barriers of extracellular matrix
(ECM) facilitated by the secretion of matrix metallopro-
teinases (MMPs)2,3. Essentially, hMSCs are characterized
by their ability for self-renewal and differentiation into
osteocytes, adipocytes, and chondrocytes4,5. However,
they also give rise to multiple additional cell types such as
cardiomyocytes and endothelial-like cells6,7. Another
peculiarity of hMSCs is their tumor tropism. Attracted by
the inflammatory milieu, hMSCs infiltrate neoplastic tis-
sues and affect tumor growth and progression3,8. In light
of these unique features, hMSCs hold great promise for
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regenerative medicine and cell-based therapy of various
diseases such as myocardial infarction and cancer9,10.
Evidence accumulates that the diverse physiological roles
of hMSCs largely stem from paracrine effects mediated by
the release of soluble biologically active factors, the so-
called secretome11. This includes cytokines, chemokines,
growth factors, and regulatory RNA molecules, many of
them encapsulated in extracellular vesicles such as exo-
somes, influencing surrounding cells to decrease inflam-
mation and improve tissue repair12–14.
Reduced oxygen concentration (hypoxia) is a major
stressor for cells and a prominent feature of the patholo-
gical states associated with tissue inflammation and cancer.
A central regulator of the cellular response to hypoxia is
hypoxia-inducible-factor-1-alpha (HIF-1α). When oxygen
is sufficient (normoxia), HIF-1α is continuously produced
and degraded, which is controlled by the oxygen-dependent
activity of prolyl hydroxylase domain-containing proteins
(PHDs). When oxygen is low, HIF-1α is stabilized and
activates the expression of genes involved in cell survival
and invasion15. Hypoxia preconditioning of hMSCs is a
novel strategy to improve their survival and therapeutical
effects16,17. However, the underlying mechanisms and the
impact of hypoxia on hMSC functionality and invasive
properties remain poorly understood.
Hypoxia/HIF-1α signaling is known to activate the
autophagic pathway18. Macroautophagy (hereafter
autophagy) is a catabolic process used by eukaryotic cells
for adapting to stress, maintaining nutrient homeostasis,
and mediating quality control by lysosomal degradation of
damaged proteins and organelles19. Autophagy is facili-
tated by several autophagy-related gene (ATG) proteins
and inhibited by the membrane-associated E3 ubiquitin-
protein ligase RNF520. Upon activation of the autophagic
pathway, cytosolic LC3-I is lipidated to form LC3-II which
is specifically recruited to the surface of autophago-
somes19. The extent of degradative activity by autophagy,
called autophagic flux, impacts proliferation and differ-
entiation of hMSCs21. However, the role of autophagy in
hMSC invasion is unclear.
Basically, all regulatory networks converge on the reg-
ulation of gene expression. MicroRNAs (miRNAs) are
small non-coding RNA molecules that play important
regulatory roles in multiple biological processes22. miR-
NAs control gene expression posttranscriptionally by
binding to their target mRNAs, which leads to the
degradation of the mRNA or suppression of its transla-
tion23. Let-7f belongs to a miRNA family of 12 members
and has been demonstrated to control survival and dif-
ferentiation of hMSCs24,25. However, little is known about
the importance of let-7f in hMSC invasion and any
potential paracrine effects of let-7f on tumor cells.
We have previously demonstrated the role of let-7f in
osteogenic differentiation of hMSCs25. In the present
study, we provide evidence that let-7f is a key regulator of
hMSC invasion. SDF-1α, inflammatory cytokines, and
hypoxia augmented endogenous let-7f that promoted
hMSC invasion via elevated autophagic flux in these cells.
Furthermore, overexpression of let-7f in hMSCs facili-
tated its exosomal release and uptake by mammary tumor
cells resulting in reduced tumor growth.
Materials and methods
Design of the study
The main objective of our study was to understand the
role of let-7f in hMSC invasion and crosstalk with tumor
cells. We studied the influence of inflammatory, hypoxic,
and autophagic conditions on let-7f expression and the
ability of hMSCs to transmigrate through barriers of
human ECM enabled by extracellular proteolysis.
Experiments in hMSCs involved the application of the
chemokine SDF-1α, inflammatory cytokines (i.e., TGF-β,
TNF-α, IL-1β), stabilization of HIF-1α (i.e., 1% O2, PHD-2
inhibitor IOX2), manipulation of autophagic flux by
chemical inducers and inhibitors of autophagy (i.e.,
rapamycin, 3-methyladenine), an inhibitor of exosome
release (i.e., GW4869), or gene manipulation (i.e., let-7f
overexpression and inhibition, siRNAs against ATG7) for
(1) transcriptional analysis and tracking of let-7f (i.e.,
qRT-PCR, fluorescently tagged miRNAs, immunocy-
tochemistry, flow cytometry), (2) analysis of downstream
effects (i.e., immunoblotting and zymography for relevant
mediators), and (3) assessment of cell functions (pro-
liferation, chemotactic invasion, cell motility, release of
exosomes). Finally, the pathophysiological significance of
hMSC-derived let-7f on tumor growth was tested in a
tumor mouse model (i.e., implantation of 3D spheroids
with a mixed composition of hMSCs and 4T1 mammary
carcinoma cells) studying the relevance of hMSCs in anti-
tumor cell therapy.
Cultivation and treatment of hMSCs
Bone-marrow-derived hMSCs were purchased from
Lonza as passage-one cells. Each lot was tested by Lonza
for purity using flow cytometry and differentiation capa-
city into osteogenic, chondrogenic, and adipogenic
lineages. The cells were positive for CD29, CD44, CD105,
and CD166, and negative for CD14, CD34, and CD45.
hMSCs were cultured as described previously25, using the
StemMACS expansion media (Miltenyi Biotec, Bergisch
Gladbach, Germany). For experiments under serum-free
conditions, hMSCs were washed with serum-free medium
(SFM) and incubated in Dulbecco Modified Eagle Med-
ium (DMEM) (PAA Laboratories, Coelbe, Germany)
supplemented with 1% Nutridoma SP (Roche Applied
Science, Mannheim, Germany) in the absence or presence
of TGF-β at 100 ng/ml, IL-1β at 50 ng/ml, TNF-α at
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50 ng/ml, and SDF-1α at 100 ng/ml (all purchased from
PeproTech, Rocky Hill, NJ).
For experiments under normoxic conditions, cells were
maintained at 37 °C in a humidified air atmosphere in the
presence of 21% O2 and 5% CO2. For experiments under
hypoxic conditions, cells were cultured in a Heracell 150i
CO2 (Thermo Scientific, Schwerte, Germany) at 37 °C in the
presence of 1% O2 and 5% CO2. All experiments were car-
ried out with hMSCs between the fourth and eighth passage
which exhibited an average cell doubling time of 96 hours.
Cells were tested by us for their ability to differentiate into
the adipogenic and osteogenic lineage as described25.
For studies on autophagy, cells were grown under serum-
free conditions in the absence or presence of 5 µM rapa-
mycin (Santa Cruz Biotechnology), 5mM 3-methyladenine
(3-MA, Sigma Aldrich), or 10 µM bafilomycin A1 (Sigma
Aldrich) as described26. Cells were routinely tested for
vitality and mycoplasma contamination.
Assessment of cell vitality and proliferation
Cell vitality and proliferation were determined by the
use of the WST-8 assay (Dojindo, Rockville, MD, USA)
that is based on the cleavage of the tetrazolium salt WST-
8 by mitochondrial dehydrogenases in viable cells fol-
lowing the manufacturer’s instructions.
qRT-PCR analysis of mRNA and miRNA expression
Isolation of total RNA from hMSCs was accomplished
using the RNeasy Mini Kit (Qiagen, Hilden, Germany),
and on-column DNase digestion with the RNase-free
DNase-set (Qiagen) was performed according to the
manufacturer’s protocols. The cDNA synthesis was
completed following the instructions of the First Strand
cDNA Synthesis Kit for RT-PCR (AMV) (Roche Applied
Science) using oligo dT primers.
qRT-PCR was carried out on a LightCycler (Roche
Applied Science) using LightCycler-FastStart DNA Mas-
ter SYBR Green I Kit (Roche Applied Science
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as
a housekeeping gene standard) according to a previously
published protocol2. PCR primer sets and kits were
applied as listed in Table S1.
miRNA expression was determined using the miScript
PCR System (Qiagen) for conversion of RNA into cDNA
and SYBR Green-based qRT-PCR for detection. Relative
expression was normalized to snord61, snord72, or U2 as
single or multiple reference genes and scaled to the sample
with the lowest expression. The respective primer
sequences and catalogue numbers are provided in Table S1.
Isolation of exosomes and quantification of let-7f in
culture supernatants
Conditioned media was centrifuged at 800 × g for
15 min at 4 °C and 100 µL of the media was applied for
isolation of vesicular RNA by using the Plasma Exosome
and Free-Circulating RNA Isolation Mini kit (Norgen
Biotek, Thorold, Canada) following the manufacturer’s
instructions. Levels of let-7f were measured by qRT-PCR
on undiluted cDNA applying the miScript technology and
normalized on the level of the spike-in cel-miR-39
(Snord61/72).
Transfection of cells with siRNA, miRNA mimics, and
miRNA Inhibitors
Specific knockdowns of HIF-1α and ATG7 in hMSCs
were accomplished by the application of RNA inter-
ference (RNAi) technology. siRNA against HIF1-α, ATG-
7, and a non-specific siRNA with no target in the human
transcriptome (used as a negative control) were purchased
from Qiagen and are listed in Table S1. For studies of
miRNA function and gene regulation, miScript miRNA
mimics and miScript miRNA inhibitors of let-7f as well as
non-specific siRNA control oligonucleotides were applied
(Qiagen). The sequences of all siRNAs, miRNA mimics,
and miRNA inhibitors used are listed in Table S1. Cells
were transfected with 20 nM of siRNAs or miRNAs by use
of Lipofectamin 2000 (Invitrogen) as described pre-
viously25. Fluorescence labeling of let-7f mimics was
accomplished by use of the LabelIT® miRNA labeling kit
Cy5 following the protocol provided by the manufacturer
(Mirus Bio, Wisconsin, USA). Cell transfection effi-
ciencies were calculated from the number of cells dis-
playing let-7f-Cy5 uptake to the total number of cells
visible in the section subjected to fluorescence microscopy
analysis with values typically averaging ~80% (Fig. S1).
Protein extraction, subcellular fractioning, and Western
blot analysis
hMSC whole protein extraction was accomplished with
a buffer containing 40mM Tris–HCl pH 8.0, 150mM
NaCl, 1% NP-40, 0.5% sodium deoxycholate and 0.1% SDS
supplemented with a mixture of proteinase and phos-
phatase inhibitors (cOmplete Mini Tablets and Phos-
STOP; Roche)27.
To obtain nuclear and cytosolic protein extracts, cells
were lysed with a buffer containing 10mM HEPES,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, and 0.05% of
EDTA for 15 min on ice. The cell lysate was centrifuged at
3,000 rpm at 4 °C for 10min. The supernatant was col-
lected (cytoplasm) whereas the pellet was resuspended
with a second buffer made of 5 mM HEPES, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 26% glycerol, and
300mM NaCl, vortexed, sonicated, and centrifuged at
30,000 × g and 4 °C for 30min. All buffers were supple-
mented with proteinase and phosphatase inhibitors
(cOmplete Mini Tablets and PhosSTOP; Roche). Fifteen
to twenty µg of lysates were resolved by SDS/poly-
acrylamide gel electrophoresis and then transferred to
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polyvinylidene difluoride membranes as described2. The
blotted membranes were incubated overnight with the
primary antibodies enlisted in Table S2 and then with
HRP-conjugated secondary antibodies (Cell Signaling
Technology). Bound antibodies were detected using the
enhanced chemiluminescence system (GE Healthcare Life
Sciences). Recombinant protein standards were used for
molecular mass determination. Densitometric quantifi-
cation was performed using a GS-800 Calibrated Densit-
ometer driven by ImageMaster-1D Elite quantification
software (GE Healthcare Life Sciences, Freiburg,
Germany) as recommended by the distributor.
Zymography analysis
Zymography analysis was carried out as described pre-
viously28. Briefly, samples were run under non-reducing
conditions without prior boiling in precast 10% poly-
acrylamide mini-gels containing 0.1% gelatin as substrate
(Invitrogen). After electrophoresis, gels were washed
twice for 15min in 2.7% Triton X-100 on a rotary shaker
to remove SDS and to allow proteins to renature. The gels
were then incubated in a buffer containing 50mM
Tris–HCl pH 7.5, 200 mM NaCl, 5 mM CaCl2, and 0.2%
Brij35 (Invitrogen) for 18 h at 37 °C. The zymograms were
stained for 90min with 0.02% Coomassie Blue R-350 in a
30% methanol/10% acetic acid solution using PhastGel-
Blue-R tablets (GE Healthcare). Areas of substrate diges-
tion appear as clear bands against a darkly stained back-
ground. Densitometric quantification of developed
zymograms was performed as described for Western
blots. As a marker for the electrophoretic mobility of
gelatinases in zymograms we used a conditioned medium
from HT1080 fibrosarcoma cells containing MMP-9 and
MMP-229.
Cell invasion assay
Studies on chemotactic invasion of hMSCs were per-
formed using the Costar Transwell chamber system (24-
well; Costar, Pleasanta, CA) as previously described in
detail2. Briefly, membrane filters with a pore size of 8 μm
(Costar) were coated with 10 μg human ECM (BD Bios-
ciences, Bedford, MA) which is mainly composed of
laminin, collagen type IV, and proteoglycans, providing a
composition similar to that of human basement mem-
branes. hMSCs (5 × 103) were placed into the upper
compartment of the invasion chamber. The lower com-
partment of the Transwell system contained 10% human
serum (PAA Laboratories) or cytokines/chemokines at
the indicated concentrations diluted in SFM as a source of
chemoattractants. Each invasion experiment was per-
formed in triplicate. After 48 h of incubation, cells that
had migrated into the lower compartment were counted.
The invasion rate was calculated from the number of
migrated cells to the total cell number.
For inhibition experiments, hMSCs were pre-incubated
for 30min without or with 10 µg/mL AMD3100 (Sigma),
a highly specific antagonist for binding of SDF-1 to
CXCR4 or 10 µg/mL Ro 206-0222, a highly specific inhi-
bitor for MMP-2, MMP-9, and MMP-1430 (kindly pro-
vided by Dr. Krell, Roche Diagnostics, Pharma Research
Penzberg, Germany). Thereafter, the cells were trans-
ferred into the upper compartment of the Transwell
system. The respective inhibitors were also added at the
same concentrations to the medium in the upper and
lower compartment. Preceding measurements had shown
that incubation of hMSCs with the inhibitors (10 µg/mL,
48 h) did not significantly affect cell viability and
proliferation.
Quantification of pericellular proteolysis
For quantitative analysis of pericellular proteolytic
activity, the QCMTM Gelatin Invadopodia Assay (Milli-
pore) was applied according to the manufacturer’s
instructions. Briefly, 104 hMSCs were plated onto a thin
uniform layer of fluorescein-labeled gelatin (green) affixed
to the bottom of glass chamber 8-well slides (Ibidi, Mar-
tinsried, Germany). After incubation for 24 h in a cell
incubator at 37 °C and 5% CO2, degraded areas of gelatin,
now devoid of fluorescence, were visualized by fluores-
cence microscopy. TRITC-labeled phalloidin (red) and
4′,6-diamidino-2-phenylindole (DAPI) (blue) were used
for counterstaining of cytoskeletal F-actin and nuclei,
respectively. Areas covered by cells and areas of degraded
gelatin were quantified using ImageJ analysis software.
µ-Slide Chemotaxis3D assay and life cell imaging analysis
Studies on directed migration of hMSCs were per-
formed using the µ-Slide Chemotaxis3D assay (Ibidi,
Martinsried, Germany) as previously described by us in
detail27. Briefly, 0.5 × 106 hMSCs suspended in SFM were
placed into the observation channel of a µ-Slide. One
medium reservoir was filled with 65 µL RPMI (GE
Healthcare) supplemented with 100 ng/mL SDF-1α
(PeproTech) and the second reservoir with RPMI only.
The µ-Slide was then incubated for 24 h at 37 °C in an
IX70 microscope (Olympus, Tokyo, Japan) that was
connected to a SensiCam camera (PCO Imaging, Kelheim,
Germany). Serial images of cell movement from a total of
30 hMSCs in each observation channel were captured by
taking pictures every 20min. The resulting images were
converted to a stack using the ImageJ software (NIH). To
determine the migration path of hMSCs, the image stacks
were analyzed by deploying the Manual Tracking plug-in
as well as the Chemotaxis and Migration Tool (both from
Ibidi) following the recommendations of the provider. To
quantify and characterize effects on both chemotactic and
migratory potential of hMSCs, the Rayleigh test, the
moving direction, and the forward migration index (FMI)
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were determined. The migration distance displays the
summary of all cell center movements between images.
Immunofluorescence microscopy analysis
hMSCs were seeded in glass-bottom chamber eight-well
slides (Ibidi) 24 h before experimental treatments. Upon
completion of treatments, cells were either fixed and
permeabilized in 100% methanol for 10min at −20 °C (for
LC3 staining) or fixed with 2% paraformaldehyde (PFA)
for 30min and permeabilized with 0.1% Triton X-100 in
PBS/BSA 1% for 30min at room temperature. The slides
were subsequently incubated overnight at 4 °C with pri-
mary antibody against HIF-1α (Table S2). Non-specific
isotype antibodies were used as negative controls. Species-
specific fluorescently conjugated secondary antibodies
were applied for 2 h at room temperature (Table S2). The
slides were embedded in Prolong® Diamond antifade
mountant (ThermoFisher Scientific) with added 4′,6-dia-
midino-2-phenylindole (DAPI) to counterstain nuclei.
Analysis was performed at 20 °C using the Olympus IX70
microscope (Olympus Europa GmbH, Hamburg, Ger-
many) with objective lens Olympus × 20 (numerical
aperture 0.55), and images were taken using SensiCam
camera (PCO Imaging, Kelheim, Germany) with Image-
ProPlus software (Media Cybernetics, Bethesda,
MD, USA).
3D spheroid cultures
3D spheroids were generated from cell suspensions of
4T1 cells or 1:1 mixtures of 4T1 cells and hMSCs. For
this, 96-well round-bottom Ultra-Low Attachment (ULA)
plates (Corning, New York, USA) were used that feature a
hydrogel layer which inhibits cellular attachment. A total
of 100 × 103 cells/well were seeded in 30 μl of complete
medium in ULA plates and maintained at 37 °C in
humidified 5% CO2 for 2 days. The resulting 3D spheroids
were examined by microscopy before application in the
mouse tumor model. For fluorescence staining of cells,
4T1 cells and hMSCs were incubated with CellTracker
Green CMFDA and CellTracker Red CMTPX, respec-
tively, (both Thermo Fisher Scientific) following the
manufacturer’s recommendations before generation of 3D
spheroids. Three weeks after spheroid transplantation,
live cells were determined in the tissue by intravital
fluorescence microscopy analysis.
Mouse 4T1 breast tumor model
All animal protocols were reviewed and approved by the
UCSF IACUC. Mice were maintained under pathogen-
free conditions in the UCSF barrier facility. The mouse
4T1 breast tumor model was used as described31 with
some modifications. Briefly, BALB/c mice (Simonsen
Laboratories, Inc.) were divided into four groups at ran-
dom with four mice per group followed by transplantation
of 3D spheroids consisting of 4T1, 4T1/hMSC-C, 4T1/
hMSC-M or 4T1/hMSC-I into cleared mammary fat pads
of the mice. The spheroids were allowed to grow for
3 weeks before the resulting tumors were removed from
the mice and subjected to weight determination by
weighing.
Statistical analysis
Statistics were calculated using Prism 8.1.2 (GraphPad
Inc.) and SPSS Statistics version 20.0 (IBM Corporation,
Armonk, NY, USA). Values are reported as mean value
and standard deviation (SD). Means were calculated from
independently performed experiments. Comparisons
between two groups were evaluated by a two-sample t
test. For three or more groups, standard one-way or two-
way ANOVA followed by Bonferroni post hoc test were
performed. A two-tailed probability value < 0.05 was
deemed as statistically significant. No blinding or rando-
mization of groups was applied.
Results
Effect of cytokines/chemokines on let-7f in hMSC invasion
hMSC migration is controlled by their response to
various inflammatory cytokines and chemokines. First, we
analyzed the effect of relevant cytokines/chemokines on
the expression of let-7f in hMSCs. The inflammatory
cytokines TGF-β, TNF-α, and IL-1β led to almost 20-fold
higher transcription of miRNA let-7f in hMSCs, treatment
with the chemokine SDF-1α to a more than 25-fold
upregulation in comparison to untreated cells (Fig. 1A).
CXCR4 is the specific cell surface receptor of SDF-1α32.
Overexpression of let-7f in hMSCs by transfection with
synthetic let-7f oligonucleotides (mimics) caused induc-
tion of CXCR4 mRNA levels (~16-fold) and protein levels
(~4-fold) compared to cells transfected with a non-
specific oligonucleotide control or an antisense oligonu-
cleotide specifically blocking let-7f activity (let-7f inhi-
bitor) (Fig. 1B). Tissue invasion requires the ability of cells
to migrate through barriers of the ECM. Therefore, we
tested the role of let-7f in this process. Overexpression of
let-7f in hMSCs significantly augmented the invasive
capabilities of these cells, as demonstrated by the use of
Transwell cell invasion assay analysis (Fig. 1C) without
affecting cell vitality (Fig. S2). In the presence of
AMD3100, a specific antagonist for the binding of SDF-1α
to CXCR433, both basal and let-7f mimic-stimulated
invasion was lower (Fig. 1C). Similarly, the addition of Ro-
206-0222, a highly specific inhibitor of MMP-2, MMP-9,
and MMP-1434, significantly reduced the invasive capa-
cities of normal and let-7f-overexpressing hMSCs
(Fig. 1C). Furthermore, we performed cell invasion assays
adding SDF-1α, TGF-β, TNF-α, or IL-1β as an exclusive
chemoattractant and SFM as controls into the lower
compartment of the Transwell chamber. hMSCs
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Fig. 1 (See legend on next page.)
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overexpressing let-7f exhibited markedly lower random
and directed cell trafficking towards the tested chemoat-
tractants in comparison to cells transfected with control
oligos (Fig. 1D).
For quantification of pericellular proteolytic activity,
hMSCs were grown on a matrix of fluorescently labeled
gelatin and subjected to microscopical analysis. The area
of degraded gelatin was significantly larger in hMSCs
transfected with let-7f mimics when compared to cells
transfected with control oligonucleotides (Fig. 1E).
Decreasing endogenous let-7f levels in hMSCs by trans-
fecting the cells with a let-7f inhibitor notably reduced
gelatin degradation in comparison to control cells
(Fig. 1E). Interestingly, hMSCs transfected with let-7f
mimics exhibited higher MMP-9 mRNA levels and pro-
tein secretion compared to control cells as determined by
qRT-PCR and zymography, respectively. In contrast, no
effect was observed in MMP-1, MMP-2, MMP-14, TIMP-
1, and TIMP-2 mRNA levels in hMSCs upon transfection
with let-7f mimics compared to control (Fig. 1F, G).
Together, these data indicate that inflammatory cyto-
kines and the chemokine SDF-1α upregulate let-7f levels
in hMSCs resulting in increased invasion and pericellular
proteolysis possibly by MMP-9 secretion.
Impact of HIF-1α and hypoxia on let-7f-promoted cell
invasion
Inflammation and cancer is frequently associated with
hypoxia-mediated activation of the HIF-1α signaling
pathway. Therefore we examined the effect of increased
HIF-1α stability on hMSC invasion. When hMSCs were
grown under normoxic conditions (21% O2), HIF-1α
protein was undetectable in the cells (Fig. 2A). Under
hypoxic conditions (1% O2) or with IOX2 treatment, a
selective inhibitor of PHD2, HIF-1α protein levels were
higher compared to control-treated cells (Fig. 2A).
Importantly, this was accompanied by higher nuclear
HIF-1α protein levels, as determined by Western blotting
and immunocytochemistry analysis (Fig. 2A). Moreover,
intracellular levels of let-7f were higher upon incubation
with hypoxia or IOX2 (Fig. 2B). This was dependent on
HIF-1α as its knockdown by siRNA-based RNAi (Fig. S3)
lowered the let-7f levels back to normoxic levels (Fig. 2B).
Functional analysis by use of the Transwell cell invasion
assay revealed that hypoxia significantly promoted the
invasive capabilities of hMSCs (Fig. 2C). This effect was
augmented upon overexpression of let-7f in cells grown
under hypoxic conditions, but attenuated in HIF-1α-
deficient hMSCs (Fig. 2C). Interestingly, hypoxia
increased the autophagic activity in hMSCs as indicated
by elevated LC3-II/LC3-I ratios in comparison to cells
grown under normoxia (Fig. 2D). This effect was dimin-
ished upon transfection of the cells with let-7f inhibitor
(Fig. 2D).
These findings suggest that hypoxia-mediated stabili-
zation of HIF-1α in hMSCs facilitates invasion through
upregulation of endogenous let-7f in these cells associated
with an activation of the autophagic pathway.
(see figure on previous page)
Fig. 1 Let-7f promotes cytokine/chemokine-directed invasion of hMSCs. A hMSCs were incubated with SDF-1α (100 ng/mL), TGF-β1 (100 ng/
mL), TNF-α (50 ng/mL), IL-1β (50 ng/mL), or left untreated (control, set as 100%) and cultivated under serum-free conditions. After 24 hours, miRNA
expression of let-7f was quantified by qRT-PCR. The values shown were normalized to snoRNA. B hMSCs transfected with synthetic let-7f miRNA
(mimic, M), antisense oligonucleotide specifically blocking let-7f activity (let-7f inhibitor, I), or non-specific oligonucleotides (control, C were cultivated
for 24 h. Cells were analyzed for CXCR4 mRNA expression by qRT-PCR. The values were normalized to GAPDH and are given in percent to control set
as 100%. Western blotting analysis of CXCR4 protein expression was performed by use of monoclonal antibodies against CXCR4. For densitometric
quantification, protein from control cells was set as 100% densitometric units (DU). Intracellular β-actin was detected as loading control. C, D hMSCs
were transfected with let-7f (mimic) or non-specific oligonucleotides (control). After 24 h, the cells were placed onto Transwell filters coated with
human ECM and incubated for 48 h in the absence (untreated) or presence of AMD3100 or the gelatinase-specific MMP inhibitor Ro-206-0222 (each
10 µg/mL). For chemoattraction, the lower compartments of the Transwell chambers contained 10% human serum (C) or SDF-1α (100 ng/mL), TGF-β
(100 ng/mL), TNF-α (50 ng/mL), or IL-1β (50 ng/mL). Serum-free medium (SFM) was used for the determination of spontaneous cell migration (D).
After 48 h, the cells that had migrated into the lower compartment were counted. Control cells were set as 100%. E For quantitative analysis of
pericellular proteolysis, the bottoms of eight-well glass chambers were coated with gelatin labeled with fluorescein. hMSCs, 24 h after transfection
with let-7f (mimic), let-7f inhibitor, or non-specific oligonucleotides (control), were seeded onto the gelatin-fluorescein matrices. After 24 h of
incubation, fluorescence microscopy analysis was performed for the assessment of non-degraded (green) vs. degraded areas of gelatin (no
fluorescence) upon counterstaining with phalloidin-TRITC conjugate (red) and DAPI (blue) for imaging of cellular actin filaments and nuclei,
respectively. The area covered by cells was recorded by phase-contrast microscopy connected to a digital camera. Scale bars indicate 5 µm. The
extent of gelatin degradation in percent to the area covered by cells (set as 100%) was calculated by adopting densitometric analysis of digitally
inverted pictures. F, G hMSCs were transfected with let-7f mimics (M), let-7f inhibitor (I), or control oligonucleotides (C) and incubated for up to 72 h.
F mRNA expression of MMP-1, MMP-2, MMP-9, MMP-14, TIMP-1, and TIMP-2 was quantified by qRT-PCR after 24 h of incubation. Results are given in
percentage of change in mRNA expression relative to control cells set as 100% upon normalization to GAPDH mRNA. G Gelatinase secretion from the
cells was determined by zymographic analysis of 20 µL-aliquots of conditioned media (CM) obtained from cells cultivated for 72 h under serum-free
conditions. Data shown in (A), (B), (E), and (F) are given as mean values ± SD of triplicate measurements (n= 3). Values in (C) are presented as
mean ± SD of one triplicate experiment representative of three independent measurements (n= 3). Data in (D) are mean values of two independent
experiments (n= 2). **P < 0.01; ***P < 0.001.
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Role of autophagy in let-7f-promoted cell invasion
Next, we studied the involvement of autophagy in let-
7f-dependent hMSC invasion in more detail. To examine
autophagosome formation in hMSCs by fluorescence
microscopy analysis, cells were transfected with GFP-
labeled LC3. Activation of the autophagic pathway in the
cells was accomplished by growth in the absence of serum
and the presence of bafilomycin A1, an inhibitor of
autophagosome degradation. Fluorescence microscopy
analysis revealed that the appearance and size of LC3-
positive puncta in the cytoplasm was augmented in LC3-
GFP-hMSCs upon overexpression of let-7f compared to
cells transfected with non-specific oligonucleotides
(Fig. 3A). In contrast, transfection of LC3-GFP-hMSCs
with let-7f inhibitor resulted in a non-punctate but rather
even distribution of LC3-GFP staining in the cytoplasm
Fig. 2 Hypoxia/HIF-1α promote cell invasion and engage autophagy through let-7f. A hMSCs were cultivated for 24 h under normoxic (21%
O2) (N) and hypoxic (1% O2) (H) conditions, or incubated for 0, 1, and 3 h with a PHD-2 inhibitor, IOX2 (10 µM). HIF-1α levels were analyzed in whole-
cell extracts (N, H), and in nuclear (Nu) and cytosolic (Cy) cell fractions by Western blotting with cytosolic β-tubulin as loading control. Subcellular
localization of HIF-1α was examined by immunocytochemistry analysis after incubation of hMSCs with IOX2 (10 µM) for 1 and 3 h. Scale bars 5 µm.
B hMSCs were transfected with HIF-1α siRNA (KD) or siRNA negative control (NC) and incubated at normoxic (21% O2) (N) or hypoxic (1% O2) (H)
conditions in the absence or presence of IOX2 (10 µM). After 24 h, RNA was collected and subjected to quantification of let-7f expression using qRT-
PCR analysis. The miRNA levels were normalized to snoRNA. The data represent the mean ± SD of triplicate experiments (n= 3); **P < 0.01, ***P <
0.001. C hMSCs were transfected with let-7f mimics (M), HIF-1α siRNA (KD), or siRNA control (NC) and then analyzed in the Transwell invasion assay for
their potential to migrate through a barrier of human ECM toward 10% human serum as chemoattractant at hypoxic (1% O2) (H) or normoxic (21%
O2) (N) conditions set as 100%. Results are presented as mean ± SD of triplicate measurements (n= 3) and representative for three independent
experiments; ***P < 0.001. D hMSCs were transfected with let-7f inhibitor (I) or control oligonucleotides (C) and cultivated under normoxia (21% O2)
(N) or hypoxia (1% O2) (H). After 24 h, cell extracts were harvested and subjected to Western blot analysis of LC-3I and LC3-II with β-tubulin as a
loading control. The LC3II/LC-3I ratio was calculated upon normalization against β-tubulin by densitometric quantification of protein bands; control
cells (C) grown under normoxia (N) were set as 100% densitometric units (DU).
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Fig. 3 Let-7f facilitates cell invasion involving activation of autophagy. A hMSCs were co-transfected with a GFP-hLC3 plasmid (green) and let-7f
mimic, inhibitor or non-specific control oligonucleotides. After 24 h of incubation under serum-free conditions to induce autophagy in the cells in the
presence of bafilomycin A1 to inhibit autophagosome depletion, cells were examined by fluorescence microscopy analysis. Scale bars 5 µm. B hMSCs
were transfected with let-7f mimics (M), inhibitor (I) or control oligonucleotides (C). After 24 h of cultivation under serum-free conditions, cell extracts
were harvested and subjected to Western blot analysis of LC-3I, LC3-II, ATG4b, RNF5, and β-actin used as a loading control. The quantification of
protein bands and LC3II/LC-3I ratio was performed upon normalization against β-tubulin by densitometry; control cells were set as 100%
densitometric units (DU). The results shown are representative for four independent experiments (n= 4). C, D Migration paths of hMSCs transfected
with GFP-LC3 plasmid and cultivated for 24 h under serum-free conditions as analyzed by fluorescence microscopy and use of the Ibidi µ-slide
Chemotaxis3D assay with 100 ng/mL SDF-1α as chemoattractant. The accumulated migration distance (µm) of 30 individual cells was determined
adopting the Ibidi Chemotaxis and Migration Software Tool. GFP-LC3 positive cells with ≥20 puncta were classified as cells with high autophagic
activity and those with less or rather diffuse staining were classified as low autophagic activity. Data shown represent the mean ± SD of triplicate
measurements (n= 3); *P < 0.05. E hMSCs were co-transfected with siRNA directed against ATG7 (KD) or non-specific siRNA control (NC) and let-7f
mimics or control oligonucleotides, or treated without and with an inhibitor of the autophagic pathway, 3-MA (5 µM), and studied for their invasive
potential using the Transwell assay with human ECM as a barrier and 10% human serum as chemoattractant. Results are mean values ± SD of
triplicate measurements and representative for three independent experiments (n= 3); ***P < 0.001.
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compared to control (Fig. 3A). These data suggested that
let-7f might promote the formation of autophagosomes in
hMSCs whereas let-7f deficiency impaired this process.
To confirm these observations, a detailed Western blot
analysis of autophagic marker proteins was performed.
Because LC3-II levels in cells show a good correlation
with the number of autophagosomes present in these
cells, the ratio of LC3-II to LC3-I is a useful measure of
the autophagic degradation activity in cells, also called
autophagic flux35. Transfection of hMSCs with let-7f
mimics and cultivation under serum-free conditions
resulted in an increase of the LC3-II/LC3-I ratio by about
twofold in comparison to cells transfected with non-
specific oligonucleotide controls or let-7f inhibitor
(Fig. 3B). Consistently, biosynthesis of a positive regulator
of autophagy, ATG4b, a proteinase that converts pro-LC3
to LC3-I, was elevated in hMSCs overexpressing let-7f
when compared to control cells, whereas protein
expression of the endogenous ATG4 inhibitor RNF5 was
diminished (Fig. 3B). Conversely, transfecting hMSCs
with let-7f inhibitor caused a decrease of ATG4b and an
increase of RNF5 levels in comparison to control cells
(Fig. 3B). These findings indicate that let-7f is a positive
regulator of the autophagic flux in hMSCs.
To assess the relevance of autophagy in hMSC motility,
we deployed life cell imaging by use of the µ-slide che-
motaxis assay. LC3-GFP-hMSCs grown under serum
deprivation to stimulate the autophagic pathway were
tracked for 24 h and then classified into two groups
according to the mainly punctate or diffuse distribution of
intracellular LC3-GFP staining corresponding to high or
low autophagic activity, respectively (Fig. 3C). Evaluation
of the tracking analysis revealed that hMSCs with pre-
dominantly punctate LC3-GFP staining showed greater
motility compared to cells with mostly diffuse staining for
LC3-GFP (Fig. 3D).
Next, we studied whether autophagy had an impact on
hMSC invasion. The knockdown of ATG7, an essential
regulator of autophagosome assembly, or the addition of a
synthetic inhibitor of autophagy, 3-MA, consistently
abolished both basal and let-7f-promoted cell migration
across barriers of human ECM, as determined by Trans-
well cell invasion assay analysis (Fig. 3E).
Together, these findings provide evidence that let-7f
facilitates hMSC motility and invasion through activation
of the autophagic pathway in these cells.
Release of let-7f from hMSCs
hMSCs secrete various types of vesicles that contain
miRNAs. We tested the hypothesis that hMSCs release
let-7f as content of exosomes. When hMSCs were culti-
vated in the presence of GW4869, an inhibitor of exosome
secretion, the intracellular levels of let-7f were sig-
nificantly increased in comparison to untreated control
cells, as determined by qRT-PCR (Fig. 4A). Similarly, the
addition of GW4869 to hMSCs overexpressing let-7f
mimics caused a doubling of intracellular let-7f quantities
in these cells compared to untreated cells (Fig. 4A).
Extracellular levels of let-7f assessed in whole culture
supernatants and exosomes isolated from culture super-
natants were considerably elevated upon transfection of
hMSCs with let-7f mimics in comparison to cells
transfected with non-specific oligonucleotide controls
(Fig. 4B). Upon blockage of exosome release by treatment
of the cells with GW4869, both basal and mimic-
stimulated secretion of let-7f was abrogated (Fig. 4B).
Next, we were interested whether chemoattractant,
hypoxia, and increased autophagy in the cells had an
influence on the exosomal release of let-7f from hMSCs.
Incubation of hMSCs with SDF-1α, oxygen deficiency, or
rapamycin, a common inducer of autophagy, resulted in a
significant augmentation of let-7f levels in exosomes iso-
lated from culture supernatants in comparison to untreated
control cells, as determined by qRT-PCR (Fig. 4C).
Taken together, our data indicate constitutive exosomal
release of let-7f in hMSCs that is augmented in response
to SDF-1α, hypoxia, and increased autophagy in the cells.
Effects of hMSC-derived let-7f on tumor cells
Exosomes play important roles in cell-to-cell commu-
nication. To test the hypothesis that let-7f released from
hMSCs may be incorporated by tumor cells, we examined
intracellular levels of let-7f in 4T1 mammary carcinoma
cells after incubation with culture supernatants obtained
from hMSCs. As determined by qRT-PCR, intracellular
let-7f in 4T1 cells was significantly elevated upon expo-
sure to conditioned media from hMSCs that had been
transfected with let-7f mimics in comparison to super-
natants from control hMSCs transfected with non-specific
oligonucleotides (Fig. 5A). This effect was absent in
4T1 cells when incubated with supernatants from let-7f-
overexpressing hMSCs treated with GW4869, an inhibitor
of exosome secretion (Fig. 5A). To approve a potential
uptake of hMSC-derived let-7f by 4T1 cells, we adopted
fluorescence microscopy analysis. hMSCs were trans-
fected with fluorescence-tagged let-7f (Fig. 5B). After the
cultivation of the cells, the supernatants were collected
and added to 4T1 cells. Subsequent microscopic exam-
ination of the 4T1 cells revealed the appearance of
fluorescent puncta in the cytoplasm (Fig. 5B). These data
indicate that 4T1 cells incorporate exogenous let-7f from
hMSC supernatants.
We next investigated the potential influence of exo-
genous let-7f on 4T1 cell functions. Cells were incubated
without and with supernatants from hMSCs transfected
with let-7f mimics or control oligonucleotides. The pro-
liferative activity of 4T1 cells was diminished with a sig-
nificantly stronger effect obtained by supernatants from
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hMSCs overexpressing let-7f compared to those from
control hMSCs, as determined by WST-8 assay analysis
(Fig. 5C). Consistently, the direct transfection of 4T1 cells
with let-7f mimics reduced cell proliferation whereas
4T1 cells transfected with let-7f inhibitor showed a slight
increase (Fig. 5D).
Furthermore, we studied the impact of let-7f on 4T1
tumor cell invasion applying the Transwell invasion assay.
Transfection of 4T1 cells with let-7f mimics caused a
massive decline in their ability for invasion through
human ECM in comparison to cells transfected with
control oligonucleotides (Fig. 5E). Conversely, 4T1 cells
overexpressing let-7f inhibitor showed a strong increase
of invasive capacities compared to cells transfected with
controls (Fig. 5E).
Together, these findings suggest that hMSC-derived let-
7f is incorporated by 4T1 tumor cells and impairs pro-
liferation and invasion of the cells.
Influence of hMSC-derived let-7f on tumor cell growth
in vivo
To provide in vivo evidence for the relevance of hMSC-
derived let-7f, we adopted a three-dimensional mouse
tumor model36 (Fig. 6A). To study the crosstalk of hMSCs
with 4T1 tumor cells, spheroids were generated consisting
of 4T1 cells and 1:1 mixtures of 4T1 cells and hMSCs that
had been transfected with let-7f mimic, let-7f inhibitor or
control oligonucleotides (Fig. 6B). Three weeks after
implantation of the spheroids into the inferior mammary
of BALB/c mice, the resulting tumor tissue was harvested
and weighted. Both visual evaluation by microscopy
(Fig. 6C) and tissue mass assessment (Fig. 6D) revealed
that the tumors harboring hMSCs were smaller in size
compared to those grown from exclusively 4T1 cells.
Importantly, the mass of tumors grown from 4T1 cells
mixed with hMSCs overexpressing let-7f was significantly
less than in tumors of 4T1 cells and hMSCs transfected
with non-specific oligonucleotides (Fig. 6C, D). In con-
trast, tumors that had developed from 4T1 cells mixed
with hMSCs overexpressing let-7f inhibitor were slightly
larger in size and weight compared to tumors obtained
from 4T1 cells combined with hMSCs transfected with
control oligonucleotides (Fig. 6C, D). CellTracker staining
analysis revealed that the tumors isolated three weeks
after mixed spheroid implantation harbored a substantial
proportion of live hMSCs (Fig. 6E). Taken together, our
data indicate the relevance of let-7f in hMSC-mediated
anti-tumor effects in vivo.
Discussion
hMSCs are characterized by their tumor tropism and
property of chemotactic migration to inflamed tissues.
Fig. 4 Let-7f, SDF-1α, hypoxia, and autophagy stimulate the exosomal release of let-7f. A–C hMSCs were transfected with let-7f mimics or
control oligonucleotides and/or incubated for 24 h in the absence (untreated) or presence of an inhibitor of exosome formation, GW4869 (10 µM), or
SDF-1α (100 ng/mL), hypoxia (1% O2), and an inducer of autophagy, rapamycin (5 µM). qRT-PCR analysis of absolute let-7f expression in hMSCs upon
normalization against snoRNA. A and in culture supernatants (Super) as well as exosomes (Exo) isolated thereof (B, C). A–C Results are given as
mean ± SD of triplicate experiments (n= 3); ***P < 0.001, **P < 0.01.
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Our published work has shown that inflammatory cyto-
kines and SDF-1α facilitate hMSC invasion by increased
MMP production by the cells2 but the underlying
regulatory mechanism was unknown. Here we provide
evidence that let-7f is a key regulator of hMSC invasion in
response to inflammatory cytokines and SDF-1α
Fig. 5 hMSC-derived let-7f is incorporated by 4T1 tumor cells impairing proliferation and invasion. A qRT-PCR analysis of absolute let-7f
expression in 4T1 mammary carcinoma cells after 24 h of cultivation under serum-free conditions without (control) and upon addition of 24 h-cell
culture supernatants obtained from hMSCs that had been transfected with let-7f mimics or control oligonucleotides grown in the absence (−) and
presence (+) of an inhibitor of exosome formation, GW4869. B hMSCs were transfected with Cy5-labeled let-7f and analyzed by fluorescence
microscopy after nuclear staining with DAPI. Scale bars 5 µm. After 48 h of cultivation under serum-free conditions, hMSC culture supernatants were
collected and added to subconfluent 4T1 cells. After 24 h of incubation, 4T1 cells were analyzed for Cy5-let-7f uptake (white arrows) adopting
fluorescence microscopy. C Assessment of cell proliferation rates in 4T1 cells upon 72 h of incubation without (untreated) and with 24 h-cell culture
supernatants obtained from hMSCs transfected with let-7f mimic or control oligonucleotides by use of the WST-8 assay. D, E 4T1 cells were
transfected with let-7f mimics, let-7f inhibitor, or control oligonucleotides. D After 72 h of incubation, cell proliferation was determined by use of the
WST-8 assay. E Cells were analyzed for their invasive potential using the Transwell assay with human ECM as a migration barrier and 10% human
serum as chemoattractant. Results are given relative to control cells set as 100%. A, C, D Data represent the mean ± SD of triplicate measurements
(n= 3); ***P < 0.001, **P < 0.01, *P < 0.05. B, E Results are mean values ± SD of a triplicate measurement and representative for three independent
experiments (n= 3); ***P < 0.001, *P < 0.05.
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previously shown to control MMP expression in these
cells2. Overexpression of let-7f in hMSCs upregulated the
SDF-1α receptor CXCR4, elevated the release of ECM-
degrading MMP-937, and augmented the level of peri-
cellular proteolysis by the cells. Under physiological
conditions, this mechanism may contribute to hMSC
recruitment in response to tissue injuries and inflamma-
tion. On a molecular basis, let-7f is likely to target
repressors of cellular susceptibility and chemotactic
migration thereby acting as promoter of hMSC invasion.
Remarkably, an opposite role has been reported on several
let-7 family members in various cancers operating as
tumor suppressors by inhibiting growth and MMP-
dependent invasion of malignant cells38–40.
Hypoxia is a hallmark of myocardial ischemia and
cancer and is known to recruit hMSCs9,41,42. Interestingly,
preconditioning of MSCs with hypoxia was shown to
improve migration, survival, and immunosuppressive
effects by these cells in vivo43–45. Our study reveals that
hypoxia/HIF-1α-stimulated hMSC migration is regulated
through let-7f which has been shown to belong to the
hypoxia-responsive family of miRNAs46. The effect Let-7b
has a similar role downstream of HIF-1α in hypoxia-
mediated cell proliferation and cell cycle regulation in
zebrafish47. Moreover, we show hypoxia/HIF-1α to sti-
mulate the autophagic pathway in hMSCs. Autophagy is
integral to the well-orchestrated programs of cellular
responses to stress and exhibits a cytoprotective role that
is balanced by apoptosis having a cytodestructive func-
tion48. Our study elucidates a mechanism by which let-7f
triggers autophagy through opposite effects on an
executor (ATG4b) and an inhibitor (RNF5) of autophagic
activity resulting in enhanced hMSC invasion. This is
consistent with previous findings in neural cells showing
that let-7 controls the migration of these cells through
positive regulation of autophagy involving the mTOR
signaling pathway49,50. Notably, MSCs engineered to
overexpress let-7f exhibited improved in vivo survival
by impaired apoptosis through let-7f targeting of
Fig. 6 hMSC-derived let-7f has anti-tumor effect in vivo. A
Schematic presentation of the experimental procedure and time line
for use of the multicellular tumor spheroid model. 1 × 106 4T1 tumor
cells were mixed in a 1:1 ratio with hMSCs transfected with let-7f
mimics (hMSC/M), let-7f inhibitor (hMSC/I) or control oligonucleotides
(hMSC/C) and cultivated for 2 days in collagen I gels. 2 × 106 4T1
tumor cells were used as a control (4T1+ 4T1). The resulting 3D tumor
spheroids were then implanted into the inferior mammary of 16
BALB/c mice (4 mice per group). After 3 weeks, the mice were
sacrificed and the tumor spheroids removed by surgery for further
analysis. B Phase-contrast microscopy pictures representative of the
resulting spheroids. Scale bars 100 µm. C Photographs of the
respective tumors after removal from the mice. Scale bars 5 mm. D
The results of quantification of the tumor masses determined by
weighing are shown. **P < 0.01, n.s. not significant. E 4T1 cells stained
with CellTracker CMFDA (green fluorescence) and hMSCs stained with
CellTracker CMTPX (red fluorescence) were mixed in a 1:1 ratio. The
resulting spheroids were implanted into the inferior mammary of
BALB/c mice and after three weeks analyzed by intravital microscopy
analysis. Photographs of the respective tumor after removal from the
mice. Scale bars 1 mm.
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endogenous caspase-324. Given the opposing role of
autophagy and apoptosis, it appears conceivable that let-7f
is a key regulator of the crosstalk between both processes.
In summary, let-7f is central in the control of hMSC
proliferation, differentiation, and migration emphasizing
its relevance in MSC-based therapies17.
The secretome of hMSCs contains numerous bioactive
factors attributed to exert therapeutic effects in multiple
diseases11. Investigating the role of let-7f and its regula-
tion in this context, we discovered a direct correlation
between endogenous and extracellular levels of let-7f in
hMSCs, indicating that the mechanisms regulating let-7f
expression in the cells are closely linked to those con-
trolling its release. Indeed, SDF-1α, hypoxia, as well as
activation of autophagy not only augmented endogenous
let-7f in hMSCs but also enhanced its secretion in exo-
somes. Accumulating evidence indicates that MSC-
derived exosomes may provide a useful drug in para-
crine anti-cancer therapies by horizontal transfer of their
cargo into host cells present in tumor tissue13,51. Our
study reveals that let-7f-enriched exosomes obtained from
let-7f-overexpressing hMSCs are incorporated by breast
cancer cells. Moreover, the let-7f-enriched exosomes
upon uptake into tumor cells impaired proliferation and
invasion more efficiently than non-let-7f-enriched exo-
somes. This can be explained by the fact that in cancer let-
7 is well known for its tumor suppressor function due to
its targeting of RAS genes essentially involved in the
progression of the disease52. Various pathomechanisms
account for significantly lowered let-7 expression levels in
numerous tumors. For instance, let-7 depletion can result
from a dysregulation of HIF-1α-controlled autophagy in
malignant cells53. Consistently, the let-7 levels in breast
cancer tissues are also low and overexpression of let-7 was
shown to block tumor cell invasion39,54. This is in
agreement with our findings on let-7f in 4T1 breast
cancer cells supporting the concept that MSCs affect host
cells largely via their paracrine factors55.
Cancer management using MSCs stems from the ability
of these cells to home to tumors. The process of tumor
tropism involves MMP secretion by MSCs and crosstalk
via the SDF-1α/CXCR4 axis56. Our findings suggest a
pivotal role of let-7f in the cytokine/chemokine-mediated
tumor tropism of hMSCs involving its positive regulation
of MMP-9 and CXCR4. Furthermore, using a mouse 4T1
breast tumor model we show that hMSCs overexpressing
let-7f in close proximity to the cancer cells display an
improved anti-tumor potential, most probably mediated
via exosomal delivery of let-7f. Similar anti-proliferative
effects of miRNA-containing exosomes from MSCs have
been described in ovarian cancer cells57. However, despite
their multiple anti-tumorigenic functions MSCs are also
involved in tumor-promoting processes including angio-
genesis and therapy resistance58. Hence, further efforts
are warranted for the optimization of preconditioning
protocols in MSC-based therapeutical applications and
for the use of MSC-derived exosomes in cell-free
therapies.
In conclusion, we have demonstrated that let-7f is a
positive regulator of hMSC invasion in response to che-
motactic cytokines and hypoxia/HIF-1α by activating the
autophagic pathway (Fig. 7). Furthermore, our results
show that overexpression of let-7f in hMSCs creates let-
7f-augmented exosomes with an improved anti-tumor
effect in vivo. Additional detailed studies are required for
a deeper knowledge of the regulatory network based on
let-7f-controlled stem cell functions relevant in hMSC´s
multifaceted roles in tissue repair and disease.
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